Shenzhen NewDEL Biotech Co., Ltd.
Company Introduction
Founded in April 2021, it is the first biotech company incubated by the Guangdong Innovation Center for Small Molecule Drug Discovery (the "Small Molecule Center"). Focusing on the major needs of innovation and development in the biomedical industry and common key technologies in the industry, the Small Molecule Center is committed to breaking through the bottleneck of key common technologies in the industrial chain, promoting the transformation of results, and creating a collaborative innovation ecosystem.
The company has two new generations of DNA encoded library technology for drug discovery,DEL2.0 (Live Cell DEL) and DEL 3.0 (SmartDEL), which has significant advantages and differentiation. Relying on our DEL technology with independent intellectual property rights, the company has established a full-life cycle system focusing on the design, research and development and industrialization of FIC/BIC drugs for unmet clinical needs, and is committed to becoming an international leading and distinctive biotech company.
Shenzhen NewDEL Biotech Co., Ltd.
Contact: Mr. Lu Email：nd@newdel.com.cn
Telephone：+86-0755-28199301 Postal code： 518110
A1503 Building 1-A YESEN Intelligent Community,1301-76 Guanguang Rd.，Longhua Dist,Shenzhen,Guangdong,China
Copyright 2021-2022深圳市新樾生物科技有限公司版权所有 粤ICP备2022125782号
